|
|||||
|
|
The significance of QT interval in drug development |
|
| Authors: | Shah Rashmi R |
| Affiliation: | Medicines Control Agency, Market Towers, 1 Nine Elms Lane, Vauxhall, London, SW8 5NQ, UK. |
| Abstract: | |
| Keywords: | astemizole Bazett cisapride clinical trials dose schedules droperidol drug development Fridericia grepafloxacin halofantrine metabolites pharmacogenetics pimozide prenylamine QT interval sertindole stereoselectivity terfenadine terodiline torsade de pointes ziprasidone |
| 本文献已被 PubMed 等数据库收录！ | |